TY - JOUR
T1 - Impact of wideband cardiac magnetic resonance on diagnosis, decision-making and outcomes in patients with implantable cardioverter defibrillators
AU - Patel, Hena N.
AU - Wang, Shuo
AU - Rao, Swati
AU - Singh, Amita
AU - Landeras, Luis
AU - Besser, Stephanie A.
AU - Carter, Spencer
AU - Mishra, Satish
AU - Nishimura, Takuro
AU - Shatz, Dalise Y.
AU - Tung, Roderick
AU - Nayak, Hemal
AU - Kawaji, Keigo
AU - Mor-Avi, Victor
AU - Patel, Amit R.
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Aims Although myocardial scar assessment using late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) imaging is frequently indicated for patients with implantable cardioverter defibrillators (ICDs), metal artefact can degrade image quality. With the new wideband technique designed to mitigate device related artefact, CMR is increasingly used in this population. However, the common clinical indications for CMR referral and impact on clinical decision-making and prognosis are not well defined Our stud was desi ned to address these knowled e a s Methods and results One hundred seventy-nine consecutive patients with an ICD (age 59 ± 13 years, 75% male) underwent CMR using cine and wideband pulse sequences for LGE imaging. Electronic medical records were reviewed to determine the reason for CMR referral, whether there was a change in clinical decision-making, and occurrence of major adverse cardiac events (MACEs). Referral indication was the most common evaluation of ventricular tachycardia (VT) substrate (n = 114, 64%), followed by cardiomyopathy (n = 53, 30%). Overall, CMR resulted in a new or changed diagnosis in 64 (36%) patients and impacted clinical management in 51 (28%). The effect on management change was highest in patients presenting with VT. A total of 77 patients (43%) experienced MACE during the follow-up period (median 1.7 years), including 65 in patients with evidence of LGE. Kaplan–Meier analysis showed that ICD patients with LGE had worse outcomes than those without LGE (P = 0.006). Conclusion The clinical yield from LGE CMR is high and provides management changing and meaningful prognostic information in a significant proportion of patients with ICDs.
AB - Aims Although myocardial scar assessment using late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) imaging is frequently indicated for patients with implantable cardioverter defibrillators (ICDs), metal artefact can degrade image quality. With the new wideband technique designed to mitigate device related artefact, CMR is increasingly used in this population. However, the common clinical indications for CMR referral and impact on clinical decision-making and prognosis are not well defined Our stud was desi ned to address these knowled e a s Methods and results One hundred seventy-nine consecutive patients with an ICD (age 59 ± 13 years, 75% male) underwent CMR using cine and wideband pulse sequences for LGE imaging. Electronic medical records were reviewed to determine the reason for CMR referral, whether there was a change in clinical decision-making, and occurrence of major adverse cardiac events (MACEs). Referral indication was the most common evaluation of ventricular tachycardia (VT) substrate (n = 114, 64%), followed by cardiomyopathy (n = 53, 30%). Overall, CMR resulted in a new or changed diagnosis in 64 (36%) patients and impacted clinical management in 51 (28%). The effect on management change was highest in patients presenting with VT. A total of 77 patients (43%) experienced MACE during the follow-up period (median 1.7 years), including 65 in patients with evidence of LGE. Kaplan–Meier analysis showed that ICD patients with LGE had worse outcomes than those without LGE (P = 0.006). Conclusion The clinical yield from LGE CMR is high and provides management changing and meaningful prognostic information in a significant proportion of patients with ICDs.
KW - cardiac magnetic resonance
KW - implantable cardioverter defibrillators
KW - late gadolinium enhancement
UR - http://www.scopus.com/inward/record.url?scp=85147045646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147045646&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jeac227
DO - 10.1093/ehjci/jeac227
M3 - Article
C2 - 36458878
AN - SCOPUS:85147045646
SN - 2047-2404
VL - 24
SP - 181
EP - 189
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 2
ER -